BioQuest Corp. is in the final Acquisition stages of BotMakers, Inc., Bolstering AI Capabilities and Market Expansion
KATY, TX / ACCESSWIRE / November 12, 2024 / AI Callers, an innovative AI-driven marketing firm and a division of BotMakers, Inc., which is in the final stages of being acquired by BioQuest Corp (OTC PINK:BQST), announced today that it has been chosen by Wefunder, one of the nation's largest pre-IPO fundraising platforms, to serve as a referred provider of AI marketing services for companies raising capital on the Wefunder platform. This selection highlights AI Callers' expertise in leveraging AI technology to support businesses in effectively reaching and engaging potential investors.
Wefunder, which hosts over 1,500 fundraises on its platform annually, generates an estimated $30 million in revenue and has facilitated the raising of over $600 million in capital for emerging companies since its inception. As one of the nation's largest pre-IPO fundraising companies, Wefunder connects startups and growth-stage businesses with essential capital to fuel development and prepare for public offerings. This collaboration with AI Callers enables Wefunder's client companies to access advanced AI marketing services, enhancing their ability to attract investors and optimize their fundraising campaigns.
AI Callers has distinguished itself by developing multi-touch marketing campaigns that include AI-powered voice-automated outbound calls, ringless voicemail, dynamic drip email, and text message campaigns. These services are provided at a flat rate per contact, making it easier for fundraising companies to accurately budget their outreach efforts. This straightforward pricing approach enables fundraisers to focus on campaign engagement without worrying about fluctuating costs.
In addition to serving Wefunder's extensive network, these services are also accessible to companies raising capital through a Regulation A offering via AI Callers' affiliated website, AIFundraising.ai. This platform, designed to support companies throughout the fundraising process, offers customizable AI-powered solutions tailored to increase investor outreach and engagement for Reg A offerings.
"We are thrilled to have been selected by Wefunder to provide our advanced AI marketing services," said Trent Daniel, Co-Founder and Product Development Director of BotMakers and Chief Operating Officer BioQiest Corp. "Our goal is to empower these fundraising companies with cutting-edge tools that amplify their message, attract investors, and maximize engagement in a competitive marketplace. Collaborating with Wefunder aligns perfectly with our mission to help high-potential companies succeed in their pre-IPO journeys."
The collaboration comes as BioQuest finalizes its acquisition of BotMakers, a strategic move designed to expand BioQuest's market presence and capabilities in the high-growth sectors of AI and digital marketing. Once the acquisition is complete, BioQuest will benefit from AI Callers' established relationships, including this pivotal new collaboration with Wefunder.
"We see tremendous potential in AI Callers' AI marketing technology to transform how fundraising companies connect with their target audiences," said Tom Hemingway, CEO of BioQuest Corp. "This selection by Wefunder not only validates AI Callers' leadership in AI marketing but also strengthens BioQuest's position in the emerging AI space as we approach the final stages of this acquisition."
With this collaboration, AI Callers will provide AI-driven marketing solutions that enable Wefunder's client companies to more efficiently communicate with potential investors, streamline campaign engagement, and make data-driven decisions to improve fundraising outcomes.
About AI Callers
AI Callers, a division of BotMakers, Inc., is a Texas-based leader in AI marketing services, specializing in conversational AI, digital outreach, and automated engagement solutions. Founded to bridge the gap between businesses and investors, AI Callers' advanced technology helps companies engage with their audiences in innovative and impactful ways. Its platform, aifundraising.ai provides these services to companies pursuing capital through Regulation A offerings, enhancing the fundraising journey with scalable, AI-powered solutions. For more information, visit botmakers.ai, aiforlawfirms.us or aiforlandlords.ai.
About Wefunder
Wefunder is one of the largest pre-IPO fundraising platforms in the U.S., generating over $30 million in annual revenue and facilitating more than $600 million in capital raised for startups and growth-stage companies. Hosting over 1,500 fundraises annually, Wefunder connects emerging companies with essential funding to fuel their development and prepare for public offerings. For more information, visit wefunder.com.
About BioQuest Corp
BioQuest Corp (OTC: BQST) is a forward-looking company dedicated to acquiring and advancing innovative technologies. Through its impending acquisition of BotMakers, BioQuest aims to expand its capabilities in AI and digital marketing to address the needs of the evolving marketplace. For more information, visit bioquestcorp.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations, estimates, projections, and assumptions made by management. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," and similar expressions are intended to identify such forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Such risks and uncertainties include, but are not limited to, the ability to successfully integrate the acquisition, execute the growth strategy, raise the necessary funds through the planned Reg A offering, and the general economic conditions affecting the AI industry. BioQuest Corp. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. For additional information on the risks and uncertainties that could affect BioQuest Corp.'s future results, please review the company's filings with the Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.
